Natural product-based therapeutics for Inflammatory cardiac disease: I3C inhibits Inflammatory dilated cardiomyopathy (DCMi) via down regulation of its target gene, 10/July/2014, 5.35 am

Tumor suppression: MiRNA-744 suppresses the expression of oncomiR-17-92 via down regulation of its target gene, 10/July/2014, 5.13 am
July 9, 2014
Small RNAs promote the generation of cardiomyocyte-like cells from differentiated cells: MiRNA-378 promotes cardiac reprogramming by decreasing Snai expression, 10/July/2014, 5.43 am
July 10, 2014
Show all

A study from W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Department of Pathology, and Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA has reported that IL-17 mediates Inflammatory cardiac diseases.

This study was published in the June 16, 2014 JEM [I.F >15] by Prof. Daniela Čiháková, Lei Wu and others from Johns Hopkins University School of Medicine, Baltimore, MD, USA.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Insights into the treatment of Inflammatory cardiac diseases: I3C inhibits Inflammatory dilated cardiomyopathy (DCMi) via down regulation of its target gene.  This study may suggest that I3C, by down regulating its target gene, it may inhibit Inflammatory dilated cardiomyopathy (DCMi). Together, this study suggests that pharmacological formulations containing “I3C or its analogues”  can be used in the treatment of Inflammatory cardiac diseases.

Idea Proposed/Formulated by: Dr L Boominathan PhD

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Courtesy: When you cite drop us a line at info@genomediscovery.org

CitationBoominathan, Natural product-based therapeutics for Inflammatory cardiac disease: I3C inhibits Inflammatory dilated cardiomyopathy (DCMi) via down regulation of its target gene, 10/July/2014, 5.35 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

*Research cooperation

Comments are closed.